Stacey Ivanchuk

Stacey Ivanchuk has extensive work experience in the field of pharmaceuticals and innovation. Stacey currently serves as the Director of Alliance Management at BlueRock Therapeutics since February 2020. Prior to this, they held the position of Director of Technology and Venture Development at TIAP - Toronto Innovation Acceleration Partners for over 10 years. Stacey also worked as a Principal Consultant at AIM Scientific Research, focusing on IP strategy and management from January 2008 to January 2010. Stacey began their career as a Scientific Advisor at Norton Rose Fulbright, where they worked from October 2005 to January 2008.

Stacey Ivanchuk holds a Ph.D. in molecular cancer biology from the University of Toronto. Prior to that, they completed their M.Sc. in cancer genetics at Queen's University and obtained a B.Sc., Hon. in biology, also from Queen's University.